FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has expanded a Class I Alaris recall to cover 15 ...
The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...
Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate ...
The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...
FRANKLIN LAKES, N.J., Aug. 20, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on a previously announced ...
Since the start of 2020, BD’s Alaris infusion pumps have been the subject of more than half-a-dozen Class I hardware and software recalls, a handful of cybersecurity warnings and a years-long ...
The FDA approved BD's (Becton, Dickinson, and Company) (NYSE:BDX) BD Alaris Infusion System with 510(k) clearance, which enables both remediation and a return to full commercial operations for the ...
FRANKLIN LAKES, N.J. , Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results